Shorts
1:14
The Hidden Danger of Postsurgery Glioblastoma Regrowth
a month ago
by
Clark Chen, MD, PhD
0:49
Using AI to Bring Trials to More Patients
a month ago
by
Shaalan Beg, MD, MBA, FASCO
0:22
Your Wednesday Wrap-Up - August 26
a month ago
by
Sabrina Serani
0:46
Balancing AI Efficiency With Human Oversight in Oncology
a month ago
by
Shaalan Beg, MD, MBA, FASCO
0:27
How Agentic AI Can Slash Clinical Trial Screening Time
a month ago
by
Shaalan Beg, MD, MBA, FASCO
0:50
Simplifying Chronic GVHD Screening for Physicians
a month ago
by
Laila Alkhouli, MD
0:35
Helping Oncologists Cut Through the Data Overload
a month ago
by
Shaalan Beg, MD, MBA, FASCO
0:43
Agentic AI: Turning Fragmented Patient Data Into Clinical Trial Matches
a month ago
by
Shaalan Beg, MD, MBA, FASCO
0:49
Proactive Supportive Care Is Key With Bispecific Therapy
a month ago
by
Natasha Edwin, MD
0:58
Why General-Purpose AI Doesn’t Cut It for Oncology
a month ago
by
Shaalan Beg, MD, MBA, FASCO
0:35
Tocilizumab May Ease Bispecific Uptake in Community Practice
a month ago
by
Natasha Edwin, MD
1:17
Navigating Early Treatment Access After Promising Trial Data
a month ago
by
David Savage, MD, PhD
0:35
Your Wednesday Wrap-Up - August 19
a month ago
by
Sabrina Serani
0:35
Why "Asian American" Isn't Just One Medical Category
2 months ago
by
Scarlett Lin Gomez, PhD, MPH
0:42
Targeting Breast Cancer's Nerve Connection
2 months ago
by
Jumana Abbadi, MD
0:32
A Surprising New Insight on How Breast Cancer Spreads
2 months ago
0:46
Can Operations Keep Pace With Oncology’s Outpatient Expansion?
2 months ago
by
Donna Berizzi, RN, DNP, OCN, NEA-BC
1:17
The Link Between Inflammation, Aging, and Cancer
2 months ago
by
Hearn Jay Cho, MD, PhD
0:34
An Often-Missed Early Step in Myeloma Care
2 months ago
by
Sagar Lonial, MD
0:17
Your Wednesday Wrap-Up - August 12th
2 months ago
0:34
Can We Cure Lung Cancer With Shorter Immunotherapy Treatment?
2 months ago
by
Ravi Salgia, MD, PhD
0:54
The Growing Case for ePROs in Community Oncology
2 months ago
by
Debra Patt, MD, PhD, MBA
0:50
Does ENDURANCE Support Lenalidomide Discontinuation At 2 Years?
2 months ago
by
Sagar Lonial, MD
0:41
OncoPRO Helps Practices Navigate ePRO Adoption
2 months ago
by
Debra Patt, MD, PhD, MBA
0:43
Can We Make Stage IV Lung Cancer Curable? New Research Offers Hope
2 months ago
by
Ravi Salgia, MD, PhD
0:36
ePRO Monitoring: Earlier Intervention, Fewer Hospitalizations
2 months ago
by
Debra Patt, MD, PhD, MBA
0:30
Why the Future of Oncology Looks Brighter Than Ever
2 months ago
by
Ravi Salgia, MD, PhD
0:43
The Future of Myeloma Care: Home Administration
2 months ago
by
Joseph Mikhael, MD
0:35
GLP-1s Linked to 34% Lower Cancer Mortality Rate
2 months ago
by
Jess Paulus, ScD
0:26
Your Wednesday Wrap-Up
2 months ago
by
Sabrina Serani
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Fast Track Designation to TRE-515 for KRAS G12C NSCLC
2
Pirtobrutinib Gains FDA Approval for Frontline CLL/SLL in Select Patients
3
NDA Submission Initiated for Zipalertinib Combo in EGFR Exon 20+ NSCLC
4
Ubamatamab Shows Durable Responses in Low-Grade Serous Ovarian Cancer
5